ImmunoGen Inc.

Available to platforms
R StocksTrader
ImmunoGen Inc. (Ticker: IMGN) is a biotechnology company focused on developing antibody-drug conjugates (ADCs) for the treatment of cancer. ADCs are targeted therapies that combine monoclonal antibodies with potent anti-cancer agents, allowing for precise delivery of the treatment to cancer cells while minimizing impact on healthy tissue. ImmunoGen’s lead product, Elahere (mirvetuximab soravtansine), is approved for the treatment of certain ovarian cancers. The company continues to advance its pipeline of ADC candidates to address unmet medical needs in oncology.

ImmunoGen Inc. (IMGN) on the NASDAQ Exchange

Company overview

ImmunoGen Inc. is a publicly listed company from USA with shares traded on NASDAQ under the ticker IMGN. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for IMGN are bid 31.23 USD and ask 31.25 USD.

Use the chart to review recent momentum, identify key price areas, and track how ImmunoGen Inc. is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add IMGN to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.

Key facts

  • Exchange: NASDAQ
  • Company: ImmunoGen Inc.
  • Ticker: IMGN
  • Country: USA
  • Bid31.23 USD
  • Ask31.25 USD
  • Quotes: real-time, auto-updated

Risk

Risk Warning: Past performance of IMGN does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for ImmunoGen Inc. (IMGN) in R StocksTrader. Create and verify your profile, fund the account, search for IMGN, and choose the instrument type available to you. Add IMGN to your Watchlist to track moves and manage open positions throughout 2025.

IMGN trades on NASDAQ and is issued by ImmunoGen Inc.. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for IMGN match your plan.

Quotes update automatically in real time. Current levels for IMGN are bid 31.23 USD and ask 31.25 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track IMGN in R StocksTrader and adjust your approach as market conditions change in 2025.